References
- Hook EB. Rates of chromosome abnormalities at different maternal ages. Obstet. Gynecol.58, 282 (1981).
- Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am. J. Obstet. Gynecol.148, 886–894 (1984).
- Manipalviratn S, Trivax B, Huang A. Genetic disorders and sex chromosome abnormalities. In: Current Diagnosis and Treatment Obstetrics and Gynecology (10th Edition). Decherny AH, Nathan L, Goodwin TM, Laufer N (Eds). McGraw-Hill, NY, USA (2007).
- Spencer K, Wallace EM, Ritoe S. Second-trimester dimeric inhibin-A in Down’s syndrome screening. Prenatal Diagn.16, 1101–1110 (1996).
- Malone F, Canick JA, Ball RH et al. First-trimester or second-trimester screening or both for Down’s syndrome. First- And Second-Trimester Evaluation of Risk (FASTER) Research Consortium. N. Engl. J. Med.353, 2001–2011 (2005).
- ACOG practice bulletin. Screening for fetal chromosomal abnormalities. Clinical management guidelines for obstetrician–gynecologists. Number 77, January 2007.
- Eddleman KA, Malone FD, Sullivan L et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet. Gynecol.108, 1067–1072 (2006).